Kayne Anderson Rudnick Investment Management LLC Abbott Laboratories Transaction History
Kayne Anderson Rudnick Investment Management LLC
- $43.7 Billion
- Q3 2024
A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 19,975 shares of ABT stock, worth $2.24 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,975
Previous 22,813
12.44%
Holding current value
$2.24 Million
Previous $2.37 Million
3.92%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding ABT
# of Institutions
3,189Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$18.9 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.62 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.38 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$5.99 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $197B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...